Could a common supplement ease jaundice? new trial investigates
NCT ID NCT06236165
First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This completed Phase 2 trial tested whether N-acetylcysteine (NAC), a common antioxidant supplement, can help people with jaundice caused by liver or bile duct issues. 44 adults took NAC twice daily for 3 months alongside standard care. Researchers measured changes in antioxidant levels, inflammation, and liver function to see if NAC provides any benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- N-acetylcysteine (NAC)
- What this could lead to
- If it works, this could point toward a simple, safe supplement to help manage jaundice and improve liver function.
- What could go wrong
- This is a small, early-phase trial with only 44 participants. Results may not apply to everyone, and the supplement may not significantly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC AND POST HEPATIC JAUNDICE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Pharmacy, Tanta University
Tanta, 31111, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.